Arecor (AIM: AREC) and Skye Bioscience Collaborate on Enhanced Formulation of Obesity Drug Candidate

Arecor Therapeutics plc (AIM: AREC)has announced a new collaboration with US-based Skye Bioscience (Nasdaq: SKYE) to develop a higher concentration formulation of nimacimab, a monoclonal antibody currently under investigation for the treatment of obesity and related metabolic conditions.

Team Kalkine | 19 May 2025

Genflow Biosciences Advances SIRT6 Gene Therapy Patent in Japan

Highlights

Team Kalkine | 15 May 2025

GSK Acquires Promising Liver Disease Drug Efimosfermin in $2 Billion Deal to Tackle Global Hepatology Crisis

In a strategic move to bolster its liver disease portfolio, GSK plc (LSE:GSK) has announced the acquisition of efimosfermin alfa, a promising investigational treatment for steatotic liver disease (SLD), from Boston Pharmaceuticals. The deal, valued at $2 billion, includes an upfront payment of $1.2 …

Team Kalkine | 14 May 2025

GSK Delivers Positive Start to 2025 with Surge in Specialty Medicines and Robust Pipeline Momentum

GSK reported Q1 2025 sales of £7.5 billion, driven by a 17% rise in Specialty Medicines and signifucant growth in HIV and oncology treatments.

Team Kalkine | 30 April 2025

Smith+Nephew Delivers Q1 Revenue Growth, Maintains 2025 Outlook Amid Global Headwinds

Highlights:

Team Kalkine | 30 April 2025

AstraZeneca Shares Dip Despite Increase in Earnings and Oncology Surge

Highlights

Team Kalkine | 29 April 2025

Reckitt Benckiser Posts Q1 2025 Results, Driven by Emerging Markets and Powerbrands

Core Reckitt delivers 3.1% like-for-like net revenue growth, led by double-digit gains in Intimate Wellness and Germ Protection.

Team Kalkine | 23 April 2025

GSK plc (LSE/NYSE: GSK) Receives CDC Recommendation for Penmenvy in Adolescent Meningococcal Vaccination

GSK plc (LSE/NYSE: GSK) has received a significant step forward in the U.S. vaccination landscape, as the CDC's Advisory Committee on Immunization Practices (ACIP) voted to recommend the use of Penmenvy, a combined meningococcal vaccine. Penmenvy, which protects against meningococcal groups A, B, C, …

Team Kalkine | 17 April 2025

Assura Agrees to £1.6 Billion Cash Acquisition by Sana Bidco

Highlights

Team Kalkine | 09 April 2025

ANGLE plc (AIM: AGL OTCQX: ANPCY) Completes Key Assays Development for AstraZeneca and Eisai

ANGLE plc (AIM:AGL OTCQX:ANPCY), a leading liquid biopsy company known for its innovative circulating tumor cell (CTC) solutions, has announced the successful completion of its development work for two significant assays with global pharmaceutical companies AstraZeneca and Eisai. ANGLE has now completed the development …

Team Kalkine | 21 March 2025

Healthcare

Arecor (AIM: AREC) and Skye Bioscience Collaborate on Enhanced Formulation of Obesity Drug Candidate

Genflow Biosciences Advances SIRT6 Gene Therapy Patent in Japan

GSK Acquires Promising Liver Disease Drug Efimosfermin in $2 Billion Deal to Tackle Global Hepatology Crisis

GSK Delivers Positive Start to 2025 with Surge in Specialty Medicines and Robust Pipeline Momentum

Smith+Nephew Delivers Q1 Revenue Growth, Maintains 2025 Outlook Amid Global Headwinds

AstraZeneca Shares Dip Despite Increase in Earnings and Oncology Surge

Reckitt Benckiser Posts Q1 2025 Results, Driven by Emerging Markets and Powerbrands

GSK plc (LSE/NYSE: GSK) Receives CDC Recommendation for Penmenvy in Adolescent Meningococcal Vaccination

Assura Agrees to £1.6 Billion Cash Acquisition by Sana Bidco

ANGLE plc (AIM: AGL OTCQX: ANPCY) Completes Key Assays Development for AstraZeneca and Eisai

Latest News

FORT Shares Climb 5%: Is Fort Technology Starting a New Momentum Run?

GFR Shares Climb 3%: Is Greenfire Resources Heating Up With Energy Buyers?

FTG Stock Climbs 4%: Is Firan Technology Group Back in Growth Mode?

FISH Stock Climbs 4%: Is Sailfish Royalty’s Precious-Metals Exposure Attracting Buyers?

GAU Shares Gain 3%: Is Galiano Gold Joining the Precious-Metals Rally?

EOG Stock Rises 5%: Is Eco Atlantic Back in Energy Investors’ Sights?